Champions Oncology’s TumorGraft™ Platform and Translational Oncology Solutions is an innovative platform technology able to accelerate the development of oncology drugs by predicting their clinical effectiveness. This platform is based on primary tumor models of cancer that preserve the original characteristics of the human tumor. As a result, Champions TumorGraft™ (CTG) technology is more predictive than traditional xenograft models and correlates 100% to actual patient outcomes.
Champions TumorGrafts™ and Translational Oncology Solutions provide:
- Early identification of agent efficacy, ideal tumor type and potential combination therapies
- A focused, accelerated and higher probability translational path into clinical trials and market launch
- Biomarker discovery and potential companion diagnostics